RECRUITING

Optimizing Surgical Decisions in Young Adults With Breast Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions. Participants will complete surveys approximately within 1 week of the surgical consult and approximately 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients/surgeons will also have their surgical consultation audio-recorded.

Official Title

Optimizing Surgical Decisions in Young Adults With Breast Cancer

Quick Facts

Study Start:2024-03-13
Study Completion:2027-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06275126

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 44 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Female aged 18-44
  2. * New diagnosis of Stage 0, 1, 2, or 3 unilateral breast cancer
  3. * English or Spanish speaking
  1. * Diagnosis of de novo Stage 4 breast cancer
  2. * Recurrent early-stage breast cancer
  3. * Bilateral breast cancer

Contacts and Locations

Study Contact

Shoshana Rosenberg, ScD, MPH
CONTACT
646-962-8041
shr4009@med.cornell.edu
Darima Dorzhieva
CONTACT
646-962-8666
dad4011@med.cornell.edu

Principal Investigator

Shoshana Rosenberg, ScD, MPH
PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Rachel Greenup, MD, MPH
PRINCIPAL_INVESTIGATOR
Yale University

Study Locations (Sites)

Yale Cancer Center
New Haven, Connecticut, 06510
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
United States
Weill Cornell Medicine
New York, New York, 10065
United States
Duke Cancer Institute
Durham, North Carolina, 27710
United States

Collaborators and Investigators

Sponsor: Weill Medical College of Cornell University

  • Shoshana Rosenberg, ScD, MPH, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University
  • Rachel Greenup, MD, MPH, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-13
Study Completion Date2027-05

Study Record Updates

Study Start Date2024-03-13
Study Completion Date2027-05

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer Stage 0
  • Breast Cancer Stage I
  • Breast Cancer Stage II
  • Breast Cancer Stage III